Detalles de la búsqueda
1.
Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.
Neurol Neurochir Pol
; 58(1): 112-119, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251955
2.
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
Neurol Neurochir Pol
; 55(2): 212-222, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33856686
3.
Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic Stroke.
J Pers Med
; 14(1)2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38248781
4.
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
Vaccines (Basel)
; 10(5)2022 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35632519
5.
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland.
Front Neurol
; 13: 913283, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35775049
6.
Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.
J Clin Med
; 10(22)2021 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830507
7.
Therapeutic applicability of helminths in autoimmune diseases - literature overview.
Prz Gastroenterol
; 14(3): 168-172, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31649786
Resultados
1 -
7
de 7
1
Próxima >
>>